Skip to main content
logo
Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,140.00
-20.00 (-0.32%)
At close: Sep 11, 2026

KOSDAQ:036480 Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
25,19625,98923,80425,56225,50023,997
Revenue Growth
2.86%9.18%-6.88%0.24%6.26%-3.24%
Gross Profit
4,9126,3203,9324,7054,6455,593
Operating Income
-666.95714.27-1,552-689.01-327.52337.11
Net Income
350.78598.19-1,769-679.681,703865.92
Earnings Per Share
-157.42-465.62-178.86448.21227.87
EPS Growth
----96.69%-42.98%

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8,9239,3889,05311,72712,8599,935
Total Debt
19,19719,97820,42824,01122,02922,352
Net Cash (Debt)
-10,274-10,589-11,374-12,284-9,170-12,418
Net Cash Growth
------
Net Cash Per Share
--2786.71-2993.19-3232.58-2413.27-3267.79

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
974.731,4102,103-1,2341,1552,203
Capital Expenditures
-358.21-355.64-795.32-1,256-2,315-2,968
Free Cash Flow
616.511,0541,308-2,490-1,160-764.71
Free Cash Flow Growth
-73.26%-19.37%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
19.49%24.32%16.52%18.40%18.22%23.31%
Operating Margin
-2.65%2.75%-6.52%-2.70%-1.28%1.41%
Pretax Margin
-0.81%1.29%-6.60%-4.23%8.86%3.51%
Profit Margin
1.39%2.30%-7.43%-2.66%6.68%3.61%
FCF Margin
2.45%4.06%5.49%-9.74%-4.55%-3.19%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
66.5146.37--22.9862.97
P/FCF Ratio
37.8426.3126.41---
PS Ratio
0.931.071.451.631.542.27